Tailoring Treatment Approaches in Psoriasis Management - Episode 6
Advancing From Topicals to Systemic Treatment in Psoriasis Management
Panelists discuss how undertreatment in psoriasis persists despite expanded therapeutic options due to multiple barriers including limited physician awareness of disease impact, insurance restrictions, socioeconomic disparities, patient concerns about medication safety, inadequate screening for comorbidities like psoriatic arthritis, outdated treatment paradigms, health care access challenges, and the failure to recognize that even limited disease in high-impact areas may warrant systemic therapy.
Video content above is prompted by the following:
- What are some potential reasons for undertreatment in psoriasis despite a wide range of available treatment options in recent years?
